Real|World Treatment Patterns and Effectiveness of Targeted and ...

Real-World Treatment Patterns and Effectiveness of Targeted and ...

This study of real-world patients with BRAF mutations confirms the importance of effective systemic therapies.

Real-World Treatment Patterns and Effectiveness of Targeted and ...

BRAF mutations (present in 2%–3% of NSCLC) are a known oncogenic driver and emerging therapeutic target. There is a scarcity of real-world data describing ...

Real-World Treatment Patterns and Effectiveness of Targeted and ...

Real-World Treatment Patterns and Effectiveness of Targeted and Immune Checkpoint Inhibitor-Based Systemic Therapy in BRAF Mutation-Positive NSCLC · 7 Citations.

Journal Pre-proof - JTO Clinical and Research Reports

Title: Real-World Treatment Patterns and Effectiveness of Targeted and Immune Checkpoint Inhibitor. Based Systemic Therapy in BRAF-Mutation ...

Real-World Treatment Patterns and Effectiveness of Patients With ...

Treatment landscape for advanced renal cell carcinoma (aRCC) has evolved quickly and few data about the real-world treatment patterns are available.

Real-world treatment patterns and outcomes in patients with HR+ ...

This real-world study describes treatment patterns and outcomes in patients treated with chemotherapy in the United States before approval of antibody–drug ...

Real-world treatment patterns and effectiveness among patients with ...

Background: Real-world treatment patterns and effectiveness often differ from those in clinical trials. This study describes the real-world ...

Real-World Treatment Patterns and Outcomes of First-Line ...

Our objectives were to summarize characteristics and treatment patterns for patients with four little-studied genomic alterations or driver-negative NSCLC.

Real-world treatment sequencing and effectiveness of second

Real-world treatment sequencing and effectiveness of second- and third-generation ALK tyrosine kinase inhibitors for ALK-positive advanced non- ...

Real-world treatment patterns and overall survival in BRAF-mutant ...

A novel approach was taken to evaluate the effectiveness of treatment sequences in order to avoid potential biases inherent to the study of treatment sequences ...

Real-world treatment patterns and effectiveness of palbociclib plus ...

Real-world treatment patterns and effectiveness of palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer aged 75 years or older.

Understanding Real-World Treatment Patterns and Clinical ... - MDPI

Real-world evidence on the uptake of novel therapies and outcomes for this patient population in Canada are limited. We conducted a population- ...

Real-World Treatment Patterns and Clinical Outcomes in Patients ...

One such agent is palbociclib, a selective cyclin-dependent kinase 4/6 inhibitor with proven efficacy for HR-positive/HER2-negative advanced breast cancer (ABC) ...

Real-world treatment patterns and clinical outcomes among...

The index date was the start date of 1L anticancer therapy during the patient identification period. The look-back period included patients' entire medical ...

Treatment Patterns and Prescribing Practices Based on Real-World ...

Providing summary dashboards to clinicians gives them a quick overview of which regimens are being used to treat their target population. This information can ...

Real-world treatment patterns and effectiveness among patients with ...

Routine clinical practice data often differ from clinical trials. This study describes real-world treatment patterns and effectiveness among ...

Real-world patterns and sequences of targeted therapy use in ...

With increasing data supporting the effectiveness of novel targeted therapies, particularly BTKi and BCL2i [Citation8–11], clinical guidelines have shifted ...

Retrospective analysis of real-world treatment patterns and clinical ...

The treatment landscape for advanced non-small cell lung cancer (aNSCLC) has evolved rapidly since immuno-oncology (IO) therapies were ...

Real-World Treatment Patterns, Overall Survival

for NSCLC is necessary for understanding the state of current therapy and the potential impact of newer therapies, in addition to defining unmet medical needs.

A Systematised Literature Review of Real-World Treatment Patterns ...

Of 16 BTC treatment guidelines (Tables S12 and S13 of the ESM), only four provided recommendations by subtype while others provided general ...